The Effect of Intra-Arterial Low-Dose Nicardipine for the Treatment of Aneurysmal Subarachnoid Hemorrhage-associated Vasospasm

  • Sung, Jae-Kyung (Department of Neurosurgery, Chungnam National University School of Medicine) ;
  • Kang, Chang-Woo (Department of Neurosurgery, Chungnam National University School of Medicine) ;
  • Kwon, Hyon-Jo (Department of Neurosurgery, Chungnam National University School of Medicine) ;
  • Koh, Hyeon-Song (Department of Neurosurgery, Chungnam National University School of Medicine) ;
  • Choi, Seung-Won (Department of Neurosurgery, Chungnam National University School of Medicine) ;
  • Song, Shi-Hun (Department of Neurosurgery, Chungnam National University School of Medicine)
  • Published : 2011.09.30

Abstract

Objective : Delayed cerebral ischemia due to vasospasm after aneurysmal subarachnoid hemorrhage (SAH) is a leading cause of morbidity and mortality. Recent reports have confirmed that intra-arterial infusion of calcium-channel blockers, which are widely used to counteract vasospasm, is effective for treating SAH with a low risk of complications. Here we report on our experience with intra-arterial nicardipine angioplasty in a consecutive series of 32 patients with SAH. Methods : This retrospective review evaluated a series of 32 consecutive patients with symptomatic vasospasm that was treated with intra-arterial nicardipine. The patients included in the study were diagnosed with aneurysmal SAH between January 2007 and February 2011. All the patients underwent microsurgical clipping or endovascular coiling. Angioplasty using intra-arterial nicardipine was performed in those patients who were refractory to medical therapy such as triple H therapy. Results : The 32 patients underwent a total of 55 procedures. The total amount of nicardipine used in each angioplasty procedure did not exceed 12 mg, with a maximum dose of 3 mg for each vessel. The Glasgow Coma Scale (GCS) score improved in all patients with an average improvement of 2.4 (range : 1~5). During angioplasty, there were no complications such as thromboembolic events and/or acute transitory spasm. The clinical results were evaluated using the modified Rankin Scale (mRS). Good outcomes (mRS 0~2) were determined in 19 (63.3%) of the 30 patients. The 11 patients (36.7%) with poor outcomes initially had a high Hunt and Hess grade (III or IV) or they had intra- operative complications (mRS: 3~6). Conclusion : Our study results support the effectiveness and safety of low-dose nicardipine when performing intra-arterial angioplasty for the treatment of vasospasm after aneurysmal SAH.

Keywords

References

  1. Abe K, Iwanaga H, Inada E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth 6:99-105, 1994 https://doi.org/10.1016/0952-8180(94)90004-3
  2. Alabadi JA, Salom JB, Torregrosa G, Miranda FJ, Jover T, Alborch E. Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 33:707-15, 1993 https://doi.org/10.1227/00006123-199310000-00022
  3. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25:819-26, 2004
  4. Barker FG II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405-14, 1996 https://doi.org/10.3171/jns.1996.84.3.0405
  5. Bejjani GK, Bank WO, Olan WJ, Sekhar LN, Mericle RA, Hopkins LN et al. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42:979-86; discussion 986-7, 1998 https://doi.org/10.1097/00006123-199805000-00013
  6. Biondia A, Ricciardia GK, Puybasset L, Abdennour L, Longo M, Chirasa J et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 25:1067-76, 2004
  7. Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intra- arterial papaverine-induced seizures: case report and review of the literature. Surg Neurol 56:159-63, 2001 https://doi.org/10.1016/S0090-3019(01)00450-5
  8. Cross DT, Moran CJ, Angtuaco EE, Milburn JM, Diringer MN, Dacey RG Jr. Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 19:1319-23, 1998
  9. Frazee JG, Bevan JA, Bevan RD, Jones KR, Bivens LV. Early treatment with diltiazem reduces delayed cerebral vascular narrowing after subarachnoid hemorrhage. Neurosurgery 23:611-5, 1988 https://doi.org/10.1227/00006123-198811000-00011
  10. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 80:788-96, 1994 https://doi.org/10.3171/jns.1994.80.5.0788
  11. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 78:537-47, 1993 https://doi.org/10.3171/jns.1993.78.4.0537
  12. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results- a report of the Cooperative Aneurysm Study. J Neurosurg 78:548-53, 1993 https://doi.org/10.3171/jns.1993.78.4.0548
  13. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm : transluminal balloon angioplasty, intra-arterial papaverine, and intra- arterial nicardipine. Neurosurg Clin N Am. 16:501-16, 2005 https://doi.org/10.1016/j.nec.2005.04.004
  14. Linfante I, Delgado-Mederos R, Andreone V, Gounis M, Hendricks L, Wakhloo AK. Angiographic and hemodynamic effect of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery 63:1080-7, 2008 https://doi.org/10.1227/01.NEU.0000327698.66596.35
  15. Lindley RI, Waddell F, Livingstone M, Sandercock P, Dennis MS, Slattery J et al. Can simple questions assess outcomes after stroke? Cerebrovasc Dis 4:314-24, 1994 https://doi.org/10.1159/000108501
  16. Mathis JM, Jensen ME, Dion JE. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 39:90-8, 1997 https://doi.org/10.1007/s002340050373
  17. Milburn JM, Moran CJ, Cross DT, Diringer MN, Pilgram TK, Dacey RG Jr. Effect of intraarterial papaverine on cerebral circulation time. AJNR Am J Neuroradiol 18:1081-5, 1997
  18. Nogueira RG, Lev MH, Roccatagliata L, Hirsch JA, Gonzalez RG, Ogilvy CS et al. Intra-arterial nicardipine infusion improves CT perfusion-measured cerebral blood flow in patients with subarachnoid hemorrhage-induced vasospasm. AJNR Am J Neuroradiol 30:160-4, 2009
  19. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. BMJ 298:636-42, 1989 https://doi.org/10.1136/bmj.298.6674.636
  20. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 44:975-9; discussion 979-80, 1999 https://doi.org/10.1097/00006123-199905000-00022
  21. Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 65:80-5, 1986 https://doi.org/10.3171/jns.1986.65.1.0080
  22. Weir B, MacDonald L. Cerebral vasospasm. Clin neurosurg 40:40-55, 1993
  23. Whiting RL, Dow RJ, Graham DJ, Mroszczak EJ. An overwiew of the pharmacology and phamocokinetics of nicardipine. Angiology 41:987-91, 1990